Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 2004; Volume 65,Issue 3

Minireview

  • You have access
    The Molecular Pharmacology of Organic Anion Transporters: from DNA to FDA?
    Satish A. Eraly, Kevin T. Bush, Rosemary V. Sampogna, Vibha Bhatnagar and Sanjay K. Nigam
    Molecular Pharmacology March 2004, 65 (3) 479-487; DOI: https://doi.org/10.1124/mol.65.3.479

Perspectives

  • You have access
    The Confluence of Population Genetics with Molecular Pharmacology at the Angiotensin II Receptor: Dawn of a New Era or Just a New Wrinkle?
    Morton P. Printz
    Molecular Pharmacology March 2004, 65 (3) 488-491; DOI: https://doi.org/10.1124/mol.65.3.488
  • You have access
    Receptor Domains Regulating μ Opioid Receptor Uncoupling and Internalization: Relevance to Opioid Tolerance
    Brian M. Cox and A. Tamara Crowder
    Molecular Pharmacology March 2004, 65 (3) 492-495; DOI: https://doi.org/10.1124/mol.65.3.492

Articles

  • You have access
    Identification of Novel Alternative Splice Variants of Human Constitutive Androstane Receptor and Characterization of Their Expression in the Liver
    Hideto Jinno, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Seiich Ishida, Mayumi Saeki, Akiko Soyama, Masaya Itoda, Tetsuji Nishimura, Yoshiro Saito, Shogo Ozawa, Masanori Ando and Jun-ichi Sawada
    Molecular Pharmacology March 2004, 65 (3) 496-502; DOI: https://doi.org/10.1124/mol.65.3.496
  • You have access
    Functional Role of Lipid Raft Microdomains in Cyclic Nucleotide-Gated Channel Activation
    James D. Brady, Thomas C. Rich, Xuan Le, Kimberlee Stafford, Cedar J. Fowler, Leatha Lynch, Jeffrey W. Karpen, R. Lane Brown and Jeffrey R. Martens
    Molecular Pharmacology March 2004, 65 (3) 503-511; DOI: https://doi.org/10.1124/mol.65.3.503
  • You have access
    Functional and Genetic Diversity in the Concentrative Nucleoside Transporter, CNT1, in Human Populations
    Jennifer H. Gray, Lara M. Mangravite, Ryan P. Owen, Thomas J. Urban, Wendy Chan, Elaine J. Carlson, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Douglas Stryke, Thomas E. Ferrin and Kathleen M. Giacomini
    Molecular Pharmacology March 2004, 65 (3) 512-519; DOI: https://doi.org/10.1124/mol.65.3.512
  • You have access
    Valproic Acid Inhibits Angiogenesis in Vitro and in Vivo
    Martin Michaelis, U. Ruth Michaelis, Ingrid Fleming, Tatyana Suhan, Jaroslav Cinatl, Roman A. Blaheta, Katrin Hoffmann, Rouslan Kotchetkov, Rudi Busse, Heinz Nau and Jindrich Cinatl
    Molecular Pharmacology March 2004, 65 (3) 520-527; DOI: https://doi.org/10.1124/mol.65.3.520
  • You have access
    Distinct Domains of the μ-Opioid Receptor Control Uncoupling and Internalization
    Jeremy Celver, Mei Xu, Wenzhen Jin, Janet Lowe and Charles Chavkin
    Molecular Pharmacology March 2004, 65 (3) 528-537; DOI: https://doi.org/10.1124/mol.65.3.528
  • You have access
    8R-Lisuride Is a Potent Stereospecific Histamine H1-Receptor Partial Agonist
    R. A. Bakker, D. M. Weiner, T. ter Laak, T. Beuming, O. P. Zuiderveld, M. Edelbroek, U. Hacksell, H. Timmerman, M. R. Brann and R. Leurs
    Molecular Pharmacology March 2004, 65 (3) 538-549; DOI: https://doi.org/10.1124/mol.65.3.538
  • You have access
    Retinoid X Receptor α Regulates Glutathione Homeostasis and Xenobiotic Detoxification Processes in Mouse Liver
    Yong Wu, Xiaoxue Zhang, Fawzia Bardag-Gorce, Rose C. V. Robel, Jonathan Aguilo, Lixin Chen, Ying Zeng, Kelly Hwang, Samuel W. French, Shelly C. Lu and Yu-Jui Y. Wan
    Molecular Pharmacology March 2004, 65 (3) 550-557; DOI: https://doi.org/10.1124/mol.65.3.550
  • You have access
    Molecular Requirements of the Human Nucleoside Transporters hCNT1, hCNT2, and hENT1
    C. Chang, P. W. Swaan, L. Y. Ngo, P. Y. Lum, S. D. Patil and J. D. Unadkat
    Molecular Pharmacology March 2004, 65 (3) 558-570; DOI: https://doi.org/10.1124/mol.65.3.558
  • You have access
    Evidence of a Functional Role for p21WAF1/CIP1 Down-Regulation in Synergistic Antileukemic Interactions between the Histone Deacetylase Inhibitor Sodium Butyrate and Flavopiridol
    Roberto R. Rosato, Jorge A. Almenara, Chunrong Yu and Steven Grant
    Molecular Pharmacology March 2004, 65 (3) 571-581; DOI: https://doi.org/10.1124/mol.65.3.571
  • You have access
    Structural Determinants Required for the Bioactivities of Prokineticins and Identification of Prokineticin Receptor Antagonists
    Clayton M. Bullock, Jia-Da Li and Qun-Yong Zhou
    Molecular Pharmacology March 2004, 65 (3) 582-588; DOI: https://doi.org/10.1124/mol.65.3.582
  • You have access
    Differential Role of Janus Family Kinases (JAKs) in Interferon-γ–Induced Lung Epithelial ICAM-1 Expression: Involving Protein Interactions between JAKs, Phospholipase Cγ, c-Src, and STAT1
    Ya-Jen Chang, Michael J. Holtzman and Ching-Chow Chen
    Molecular Pharmacology March 2004, 65 (3) 589-598; DOI: https://doi.org/10.1124/mol.65.3.589
  • You have access
    Caffeic Acid Esters Activate TREK-1 Potassium Channels and Inhibit Depolarization-Dependent Secretion
    Sanjay Danthi, Judith A. Enyeart and John J. Enyeart
    Molecular Pharmacology March 2004, 65 (3) 599-610; DOI: https://doi.org/10.1124/mol.65.3.599
  • You have access
    Up-Regulation of Brain Nicotinic Acetylcholine Receptors in the Rat during Long-Term Self-Administration of Nicotine: Disproportionate Increase of the α6 Subunit
    Steven L. Parker, Yitong Fu, Kathleen McAllen, Jianhong Luo, J. Michael McIntosh, Jon M. Lindstrom and Burt M. Sharp
    Molecular Pharmacology March 2004, 65 (3) 611-622; DOI: https://doi.org/10.1124/mol.65.3.611
  • You have access
    Vasopressin Stimulates Insulin Release from Islet Cells through V1b Receptors: a Combined Pharmacological/Knockout Approach
    Sayuri Oshikawa, Akito Tanoue, Taka-aki Koshimizu, Yoko Kitagawa and Gozoh Tsujimoto
    Molecular Pharmacology March 2004, 65 (3) 623-629; DOI: https://doi.org/10.1124/mol.65.3.623
  • You have access
    Blockage of Intermediate-Conductance Ca2+-Activated K+ Channels Inhibit Human Pancreatic Cancer Cell Growth in Vitro
    Heike Jäger, Tobias Dreker, Anita Buck, Klaudia Giehl, Thomas Gress and Stephan Grissmer
    Molecular Pharmacology March 2004, 65 (3) 630-638; DOI: https://doi.org/10.1124/mol.65.3.630
  • You have access
    Dipyridamole Alters Cardiac Substrate Preference by Inducing Translocation of FAT/CD36, but Not That of GLUT4
    Joost J. F. P. Luiken, Susan L. M. Coort, Jodil Willems, Will A. Coumans, Arend Bonen and Jan F. C. Glatz
    Molecular Pharmacology March 2004, 65 (3) 639-645; DOI: https://doi.org/10.1124/mol.65.3.639
  • You have access
    Selective Knock-Down of P2X7 ATP Receptor Function by Dominant-Negative Subunits
    Ramin Raouf, Yassar Chakfe, Dominique Blais, Audrey Speelman, Eric Boué-Grabot, Duncan Henderson and Philippe Séguéla
    Molecular Pharmacology March 2004, 65 (3) 646-654; DOI: https://doi.org/10.1124/mol.65.3.646
  • You have access
    Protein Adduct-Trapping by Hydrazinophthalazine Drugs: Mechanisms of Cytoprotection Against Acrolein-Mediated Toxicity
    Philip C. Burcham, Frank R. Fontaine, Lisa M. Kaminskas, Dennis R. Petersen and Simon M. Pyke
    Molecular Pharmacology March 2004, 65 (3) 655-664; DOI: https://doi.org/10.1124/mol.65.3.655
  • You have access
    Endocannabinoids Modulate N-Type Calcium Channels and G-Protein-Coupled Inwardly Rectifying Potassium Channels via CB1 Cannabinoid Receptors Heterologously Expressed in Mammalian Neurons
    Juan Guo and Stephen R. Ikeda
    Molecular Pharmacology March 2004, 65 (3) 665-674; DOI: https://doi.org/10.1124/mol.65.3.665
  • You have access
    The Molecular Basis of the Action of Disulfiram as a Modulator of the Multidrug Resistance-Linked ATP Binding Cassette Transporters MDR1 (ABCB1) and MRP1 (ABCC1)
    Zuben E. Sauna, Xiang-Hong Peng, Krishnamachary Nandigama, Samrawit Tekle and Suresh V. Ambudkar
    Molecular Pharmacology March 2004, 65 (3) 675-684; DOI: https://doi.org/10.1124/mol.65.3.675
  • You have access
    Combinatorial Interaction of Scorpion Toxins Lqh-2, Lqh-3, and LqhαIT with Sodium Channel Receptor Sites-3
    Enrico Leipold, Songqing Lu, Dalia Gordon, Alfred Hansel and Stefan H. Heinemann
    Molecular Pharmacology March 2004, 65 (3) 685-691; DOI: https://doi.org/10.1124/mol.65.3.685
  • You have access
    Uptake Inhibitors but not Substrates Induce Protease Resistance in Extracellular Loop Two of the Dopamine Transporter
    Jon D. Gaffaney and Roxanne A. Vaughan
    Molecular Pharmacology March 2004, 65 (3) 692-701; DOI: https://doi.org/10.1124/mol.65.3.692
  • You have access
    Random Mutagenesis of the Human Adenosine A2B Receptor Followed by Growth Selection in Yeast. Identification of Constitutively Active and Gain of Function Mutations
    Margot W. Beukers, Joris van Oppenraaij, Patrick P. W. van der Hoorn, Clara C. Blad, Hans den Dulk, Jaap Brouwer and Adriaan P. IJzerman
    Molecular Pharmacology March 2004, 65 (3) 702-710; DOI: https://doi.org/10.1124/mol.65.3.702
  • You have access
    Expression of A3 Adenosine Receptors in Human Lymphocytes: Up-Regulation in T Cell Activation
    Stefania Gessi, Katia Varani, Stefania Merighi, Elena Cattabriga, Arianna Avitabile, Riccardo Gavioli, Cinzia Fortini, Edward Leung, Stephen Mac Lennan and Pier Andrea Borea
    Molecular Pharmacology March 2004, 65 (3) 711-719; DOI: https://doi.org/10.1124/mol.65.3.711
  • You have access
    Dehydroepiandrosterone Sulfotransferase Is a Target for Transcriptional Induction by the Vitamin D Receptor
    Ibtissam Echchgadda, Chung S. Song, Arun K. Roy and Bandana Chatterjee
    Molecular Pharmacology March 2004, 65 (3) 720-729; DOI: https://doi.org/10.1124/mol.65.3.720
  • You have access
    Regulation of Mouse Renal CYP2J5 Expression by Sex Hormones
    Jixiang Ma, Joan Graves, J. Alyce Bradbury, Yun Zhao, Deborah L. Swope, Lorraine King, Wei Qu, James Clark, Page Myers, Vickie Walker, Jonathan Lindzey, Kenneth S. Korach and Darryl C. Zeldin
    Molecular Pharmacology March 2004, 65 (3) 730-743; DOI: https://doi.org/10.1124/mol.65.3.730
  • You have access
    SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-β Type I Receptors ALK4, ALK5, and ALK7
    Stacey DaCosta Byfield, Christopher Major, Nicholas J. Laping and Anita B. Roberts
    Molecular Pharmacology March 2004, 65 (3) 744-752; DOI: https://doi.org/10.1124/mol.65.3.744
  • You have access
    Ligand Function at Constitutively Active Receptor Mutants Is Affected by Two Distinct Yet Interacting Mechanisms
    Martin Beinborn, Yong Ren, Michael Bläker, Ci Chen and Alan S. Kopin
    Molecular Pharmacology March 2004, 65 (3) 753-760; DOI: https://doi.org/10.1124/mol.65.3.753
  • You have access
    DAXX, FLASH, and FAF-1 Modulate Mineralocorticoid and Glucocorticoid Receptor-Mediated Transcription in Hippocampal Cells—Toward a Basis for the Opposite Actions Elicited by Two Nuclear Receptors?
    D. Obradović, M. Tirard, Zs. Némethy, O. Hirsch, H. Gronemeyer and O. F. X. Almeida
    Molecular Pharmacology March 2004, 65 (3) 761-769; DOI: https://doi.org/10.1124/mol.65.3.761
  • You have access
    Loss-of-Function Polymorphic Variants of the Human Angiotensin II Type 1 Receptor
    Jakob Lerche Hansen, Stig Haunsø, Mark R. Brann, Søren P. Sheikh and David M. Weiner
    Molecular Pharmacology March 2004, 65 (3) 770-777; DOI: https://doi.org/10.1124/mol.65.3.770
  • You have access
    Phorbol 12-Myristate 13-Acetate Protects Jurkat Cells from Methylglyoxal-Induced Apoptosis by Preventing c-Jun N-Terminal Kinase-Mediated Leakage of Cytochrome c in an Extracellular Signal-Regulated Kinase-Dependent Manner
    Yoshikazu Takagi, Jun Du, Xiu-Yang Ma, Izumi Nakashima and Fumihiko Nagase
    Molecular Pharmacology March 2004, 65 (3) 778-787; DOI: https://doi.org/10.1124/mol.65.3.778
  • You have access
    An Apamin- and Scyllatoxin-Insensitive Isoform of the Human SK3 Channel
    Oliver H. Wittekindt, Violeta Visan, Hiroaki Tomita, Faiqa Imtiaz, Jay J. Gargus, Frank Lehmann-Horn, Stephan Grissmer and Deborah J. Morris-Rosendahl
    Molecular Pharmacology March 2004, 65 (3) 788-801; DOI: https://doi.org/10.1124/mol.65.3.788
  • You have access
    Effects of SEA0400 on Mutant NCX1.1 Na+-Ca2+ Exchangers with Altered Ionic Regulation
    Ron Bouchard, Alexander Omelchenko, Hoa Dinh Le, Platon Choptiany, Toshio Matsuda, Akemichi Baba, Kenzo Takahashi, Debora A. Nicoll, Kenneth D. Philipson, Mark Hnatowich and Larry V. Hryshko
    Molecular Pharmacology March 2004, 65 (3) 802-810; DOI: https://doi.org/10.1124/mol.65.3.802
  • You have access
    Correction to “Agonist Binding and Gq-Stimulating Activities of the Purified Human P2Y1 Receptor”
    Molecular Pharmacology March 2004, 65 (3) 811; DOI: https://doi.org/10.1124/mol.65.3.811
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 65 (3)
Molecular Pharmacology
Vol. 65, Issue 3
1 Mar 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Minireview
  • Perspectives
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics